You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Seasonal malaria chemoprevention: successes and missed opportunities
|
|---|---|
| Published in |
Malaria Journal, November 2017
|
| DOI | 10.1186/s12936-017-2132-1 |
| Pubmed ID | |
| Authors |
Matthew E. Coldiron, Lorenz Von Seidlein, Rebecca F. Grais |
| Abstract |
Seasonal malaria chemoprevention (SMC) was recommended in 2012 for young children in the Sahel during the peak malaria transmission season. Children are given a single dose of sulfadoxine/pyrimethamine combined with a 3-day course of amodiaquine, once a month for up to 4 months. Roll-out and scale-up of SMC has been impressive, with 12 million children receiving the intervention in 2016. There is evidence of its overall benefit in routine implementation settings, and a meta-analysis of clinical trial data showed a 75% decrease in clinical malaria compared to placebo. SMC is not free of shortcomings. Its target zone includes many hard-to-reach areas, both because of poor infrastructure and because of political instability. Treatment adherence to a 3-day course of preventive treatment has not been fully documented, and could prove challenging. As SMC is scaled up, integration into a broader, community-based paradigm which includes other preventive and curative activities may prove beneficial, both for health systems and for recipients. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Science communicators (journalists, bloggers, editors) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 180 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 180 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 30 | 17% |
| Researcher | 21 | 12% |
| Student > Bachelor | 16 | 9% |
| Student > Postgraduate | 10 | 6% |
| Student > Ph. D. Student | 10 | 6% |
| Other | 26 | 14% |
| Unknown | 67 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 17% |
| Nursing and Health Professions | 19 | 11% |
| Agricultural and Biological Sciences | 16 | 9% |
| Biochemistry, Genetics and Molecular Biology | 12 | 7% |
| Immunology and Microbiology | 11 | 6% |
| Other | 22 | 12% |
| Unknown | 69 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2017.
All research outputs
#16,712,239
of 24,580,204 outputs
Outputs from Malaria Journal
#4,607
of 5,786 outputs
Outputs of similar age
#276,710
of 448,449 outputs
Outputs of similar age from Malaria Journal
#94
of 111 outputs
Altmetric has tracked 24,580,204 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,786 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,449 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 111 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.